A trial in Great Brtain found the device couldÂ reduce the frequency and severity of migraines, but not prevent them, as investors had hoped. StarFlex is approved for treating a congenital heart defect called patent foramen ovale, or PFO, in which a flap of tissue is pushed open when a patient is under stress. The British study shows that there is probably a link between PFO and migraines. What exactly it is, andÂ to what extentÂ StarFlex can help, will be the subject of future studies.
MDDI Online is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.